THYROID CANCER

This adverse event was reported 12047 times

These drugs are most commonly taken by patients reporting THYROID CANCER:

# Drug Count
0 RANITIDINE 2299
1 LEVOTHYROXINE SODIUM 705
2 RANITIDINE HYDROCHLORIDE 590
3 ADALIMUMAB 367
4 ETANERCEPT 298
5 METHOTREXATE SODIUM 289
6 INTERFERON BETA-1A 266
7 METHOTREXATE 260
8 EXENATIDE 244
9 ERGOCALCIFEROL 237
See all common drugs associated with THYROID CANCER

THYROID CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANGELICA DAHURICA EXTRACTT, ASIATIC ACID 1 0.0667
1 ALUMINUM CHLOROHYDRATE 1 0.0222
2 AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE 1 0.0200
3 SODIUM IODIDE I 123 17 0.0181
4 SODIUM IODIDE I 131 17 0.0177
5 RANITIDINE 2299 0.0116
6 RANITIDINE HYDROCHLORIDE 590 0.0109
7 THYROTROPIN ALFA 11 0.0106
8 GOLIMUMAB 102 0.0081
9 ERGOCALCIFEROL 237 0.0080
See all drugs enriched for association with THYROID CANCER

THYROID CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 27 0.0392
1 Oxaborole Antifungal [EPC] 1 0.0143
2 Thyroid Stimulating Hormone [EPC] 11 0.0106
3 Provitamin D2 Compound [EPC] 237 0.0080
4 Guanylate Cyclase-C Agonist [EPC] 16 0.0077
5 Actinomycin [EPC] 15 0.0068
6 Interleukin-17A Antagonist [EPC] 96 0.0026
7 Gamma Secretase Inhibitor [EPC] 2 0.0022
8 Vitamin D3 Analog [EPC] 40 0.0020
9 Integrin Receptor Antagonist [EPC] 165 0.0019
See all drug classes enriched for association with THYROID CANCER